NP/VP35 inhibitors (Microbiotix)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNP/VP35 inhibitors (Microbiotix)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase cofactor VP35 inhibitorsNucleoprotein inhibitors
TargetsNucleoproteinPolymerase cofactor VP35
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobiotix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington UniversityIcahn School Of Medicine At Mount SinaiMicrobiotix Inc
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A